Cargando…
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy
PURPOSE: For patients with psoriasis, treatment adherence and persistence are fundamental if therapeutic goals are to be met. Patient Support Programs (PSPs) may be used as a support tool to assist patients and health care professionals optimize treatment and improve disease management. PATIENTS AND...
Autores principales: | Argenziano, Giuseppe, Amerio, Paolo, Aragone, Maria Grazia, Baggini, Ginevra, Baldari, Manuela, Castelli, Gianpiero, Coppola, Simmaco, Costanzo, Antonio, De Pasquale, Rocco, Fargnoli, Maria Concetta, Foti, Caterina, Giofrè, Claudia, Lembo, Serena, Leporati, Claudia, Loconsole, Francesco, Malara, Giovanna, Peris, Ketty, Richetta, Antonio Giovanni, Savoia, Paola, Tiberio, Rossana, Travaglini, Massimo, Uzzauto, Maria Teresa, Bianchi, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610754/ https://www.ncbi.nlm.nih.gov/pubmed/34824526 http://dx.doi.org/10.2147/PPA.S326498 |
Ejemplares similares
-
Secukinumab for Psoriasis in Obese Patients: Minireview and Clinical Experience
por: Tiberio, Rossana, et al.
Publicado: (2019) -
Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
por: Fargnoli, Maria Concetta
Publicado: (2019) -
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study
por: TALAMONTI, Marina, et al.
Publicado: (2021) -
Interleukin-17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery following Secukinumab Administration
por: Frustaci, Andrea, et al.
Publicado: (2023) -
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
por: Stingeni, Luca, et al.
Publicado: (2023)